Chaparro, Marķa <br/><br/>
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease.  [electronic resource] 

 -  European journal of gastroenterology & hepatology  05 2020 
 - 588-596 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5687 
<br/><br/><label>Standard No.: </label>10.1097/MEG.0000000000001706  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--pharmacokinetics<br/>Adult<br/>Anti-Inflammatory Agents--pharmacokinetics<br/>Antibodies, Monoclonal--blood<br/>Crohn Disease--blood<br/>Female<br/>Humans<br/>Induction Chemotherapy--methods<br/>Infliximab--pharmacokinetics<br/>Male<br/>Necrosis<br/>Prospective Studies<br/>Remission Induction<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors